Higher Vulnerability and Stress Sensitivity of Neuronal Precursor Cells Carrying an Alpha-Synuclein Gene Triplication
暂无分享,去创建一个
R. Jaenisch | J. Langston | T. Jovin | D. Arndt-Jovin | A. Flierl | L. Falomir-Lockhart | F. Soldner | Jayne Hesley | B. Schüle | S. K. Mak | Luis M. A. Oliveira | L. M. Oliveira | Lisandro J. Falomir-Lockhart
[1] Michael J. Devine,et al. A cell culture model for monitoring α-synuclein cell-to-cell transfer , 2015, Neurobiology of Disease.
[2] E. Cadenas,et al. Mitochondrial energy metabolism and redox signaling in brain aging and neurodegeneration. , 2014, Antioxidants & redox signaling.
[3] Michael D. Pluth,et al. Identification and Rescue of α-Synuclein Toxicity in Parkinson Patient–Derived Neurons , 2013, Science.
[4] Torsten Kluba,et al. Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression. , 2013, Cell stem cell.
[5] K. Ess,et al. Genetic risk for Parkinson's disease correlates with alterations in neuronal manganese sensitivity between two human subjects. , 2012, Neurotoxicology.
[6] J. Yates,et al. Progressive degeneration of human neural stem cells caused by pathogenic LRRK2 , 2012, Nature.
[7] Christine Klein,et al. Pharmacological Rescue of Mitochondrial Deficits in iPSC-Derived Neural Cells from Patients with Familial Parkinson’s Disease , 2012, Science Translational Medicine.
[8] Kevin W Eliceiri,et al. NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.
[9] B. Hyman,et al. Apoptotic and non-apoptotic roles of caspases in neuronal physiology and pathophysiology , 2012, Nature Reviews Neuroscience.
[10] Guang Shi,et al. The Emerging Role of Proteolysis in Mitochondrial Quality Control and the Etiology of Parkinson's Disease , 2012, Parkinson's disease.
[11] M. Memo,et al. Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease , 2012, EMBO molecular medicine.
[12] N. Naidoo,et al. The endoplasmic reticulum stress response in aging and age-related diseases , 2012, Front. Physio..
[13] J. Langston,et al. Small Molecules Greatly Improve Conversion of Human-Induced Pluripotent Stem Cells to the Neuronal Lineage , 2012, Stem cells international.
[14] A. Negro,et al. α-Synuclein Controls Mitochondrial Calcium Homeostasis by Enhancing Endoplasmic Reticulum-Mitochondria Interactions* , 2012, The Journal of Biological Chemistry.
[15] L. Peterson,et al. Oxidative Stress and Microglial Cells in Parkinson's Disease , 2012, Mediators of inflammation.
[16] Timothy J. Nelson,et al. Mitochondria in control of cell fate. , 2012, Circulation research.
[17] S. Grimm. The ER-mitochondria interface: the social network of cell death. , 2012, Biochimica et biophysica acta.
[18] D. Steindler,et al. Stem cell pathologies and neurological disease , 2012, Modern Pathology.
[19] C. Cotman,et al. Caspase-3 activation as a bifurcation point between plasticity and cell death , 2012, Neuroscience Bulletin.
[20] Lief E. Fenno,et al. SNCA Triplication Parkinson's Patient's iPSC-derived DA Neurons Accumulate α-Synuclein and Are Susceptible to Oxidative Stress , 2011, PloS one.
[21] Jeffrey D. Zaremba,et al. MEF2C Enhances Dopaminergic Neuron Differentiation of Human Embryonic Stem Cells in a Parkinsonian Rat Model , 2011, PloS one.
[22] G. Schatten,et al. Energy Metabolism in Human Pluripotent Stem Cells and Their Differentiated Counterparts , 2011, PloS one.
[23] Guo-qiang Lu,et al. Impaired CD200-CD200R-mediated microglia silencing enhances midbrain dopaminergic neurodegeneration: roles of aging, superoxide, NADPH oxidase, and p38 MAPK. , 2011, Free radical biology & medicine.
[24] D. Krainc,et al. Mitochondrial Parkin Recruitment Is Impaired in Neurons Derived from Mutant PINK1 Induced Pluripotent Stem Cells , 2011, The Journal of Neuroscience.
[25] R. Nussbaum,et al. Direct Membrane Association Drives Mitochondrial Fission by the Parkinson Disease-associated Protein α-Synuclein*♦ , 2011, The Journal of Biological Chemistry.
[26] G. Reiser,et al. Calcium dysregulation and homeostasis of neural calcium in the molecular mechanisms of neurodegenerative diseases provide multiple targets for neuroprotection. , 2011, Antioxidants & redox signaling.
[27] P. Blain,et al. Mitochondrial Dysfunction in Parkinson's Disease , 2011, Parkinson's disease.
[28] Blake Byers,et al. LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. , 2011, Cell stem cell.
[29] F. Gage,et al. Adult neurogenesis and neurite outgrowth are impaired in LRRK2 G2019S mice , 2011, Neurobiology of Disease.
[30] C. Tanner,et al. Rotenone, Paraquat, and Parkinson’s Disease , 2011, Environmental health perspectives.
[31] A. Pyle,et al. Proliferative neural stem cells have high endogenous ROS levels that regulate self-renewal and neurogenesis in a PI3K/Akt-dependant manner. , 2011, Cell stem cell.
[32] J. Andersen,et al. Mitochondrial alpha-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo , 2010, Neuroscience Letters.
[33] Wayne F. Patton,et al. Novel Cell- and Tissue-Based Assays for Detecting Misfolded and Aggregated Protein Accumulation Within Aggresomes and Inclusion Bodies , 2010, Cell Biochemistry and Biophysics.
[34] Y. Suh,et al. Amyloid Precursor Protein Binding Protein-1 Modulates Cell Cycle Progression in Fetal Neural Stem Cells , 2010, PloS one.
[35] J. Rehman. Empowering self-renewal and differentiation: the role of mitochondria in stem cells , 2010, Journal of Molecular Medicine.
[36] Cindy E J Dieteren,et al. Mammalian mitochondrial complex I: biogenesis, regulation, and reactive oxygen species generation. , 2010, Antioxidants & redox signaling.
[37] Yau-Huei Wei,et al. Upregulation of mitochondrial function and antioxidant defense in the differentiation of stem cells. , 2010, Biochimica et biophysica acta.
[38] Yusuke Nakamura,et al. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease , 2009, Nature Genetics.
[39] G. Hajnóczky,et al. SR/ER-mitochondrial local communication: calcium and ROS. , 2009, Biochimica et biophysica acta.
[40] R. Taneja,et al. Oxidative stress regulation of stem and progenitor cells. , 2009, Antioxidants & redox signaling.
[41] D. Freyssenet,et al. Control of mitochondrial biogenesis, ROS level, and cytosolic Ca2+ concentration during the cell cycle and the onset of differentiation in L6E9 myoblasts. , 2009, American journal of physiology. Cell physiology.
[42] Rudolf Jaenisch,et al. Parkinson's Disease Patient-Derived Induced Pluripotent Stem Cells Free of Viral Reprogramming Factors , 2009, Cell.
[43] L. Colombaioni,et al. Mitochondrial remodeling in differentiating neuroblasts , 2009, Brain Research.
[44] V. Bunik,et al. α-Ketoglutarate dehydrogenase contributes to production of reactive oxygen species in glutamate-stimulated hippocampal neurons in situ , 2009, Neuroscience.
[45] H. Brown-Borg,et al. Mitochondrial localization of alpha-synuclein protein in alpha-synuclein overexpressing cells , 2008, Neuroscience Letters.
[46] M. Kyba,et al. Caspase activity mediates the differentiation of embryonic stem cells. , 2008, Cell stem cell.
[47] N. Avadhani,et al. Mitochondrial Import and Accumulation of α-Synuclein Impair Complex I in Human Dopaminergic Neuronal Cultures and Parkinson Disease Brain* , 2008, Journal of Biological Chemistry.
[48] M. Farrer,et al. α-Synuclein and Parkinson disease susceptibility , 2007, Neurology.
[49] N. Nukina,et al. Assembly of Lysine 63-linked Ubiquitin Conjugates by Phosphorylated α-Synuclein Implies Lewy Body Biogenesis* , 2007, Journal of Biological Chemistry.
[50] Andre Terzic,et al. Mitochondrial oxidative metabolism is required for the cardiac differentiation of stem cells , 2007, Nature Clinical Practice Cardiovascular Medicine.
[51] D. Beach,et al. A high glycolytic flux supports the proliferative potential of murine embryonic stem cells. , 2006, Antioxidants & redox signaling.
[52] C. Mannella,et al. Structural and functional features and significance of the physical linkage between ER and mitochondria , 2006, The Journal of cell biology.
[53] Ronald J A Wanders,et al. Biochemistry of mammalian peroxisomes revisited. , 2006, Annual review of biochemistry.
[54] S. Orrenius,et al. Overexpression of glutaredoxin 2 attenuates apoptosis by preventing cytochrome c release. , 2005, Biochemical and biophysical research communications.
[55] P. Brookes,et al. Calcium, ATP, and ROS: a mitochondrial love-hate triangle. , 2004, American journal of physiology. Cell physiology.
[56] Janel O. Johnson,et al. α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.
[57] Gary Fiskum,et al. Regulation of hydrogen peroxide production by brain mitochondria by calcium and Bax , 2002, Journal of neurochemistry.
[58] P. Lebaron,et al. Effectiveness of SYTOX Green Stain for Bacterial Viability Assessment , 1998, Applied and Environmental Microbiology.
[59] Robert L. Nussbaum,et al. Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .
[60] C Haanen,et al. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. , 1995, Journal of immunological methods.
[61] R. Haworth,et al. Relationship between configuration, function, and permeability in calcium-treated mitochondria. , 1976, The Journal of biological chemistry.
[62] Hyun Min Jeon,et al. Molecular and Cellular Pathobiology Wnt / Snail Signaling Regulates Cytochrome c Oxidase and Glucose Metabolism , 2012 .
[63] Michael K Pugsley,et al. An overview of colorimetric assay methods used to assess survival or proliferation of mammalian cells. , 2011, Proceedings of the Western Pharmacology Society.
[64] J. Langston,et al. Mitochondrial dysfunction in skin fibroblasts from a Parkinson's disease patient with an alpha-synuclein triplication. , 2011, Journal of Parkinson's disease.
[65] D. Wallace,et al. Energetics, epigenetics, mitochondrial genetics. , 2010, Mitochondrion.
[66] M. Farrer,et al. alpha-Synuclein and Parkinson disease susceptibility. , 2007, Neurology.
[67] S E Ide,et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. , 1997, Science.